23,000
Participants
Start Date
August 24, 2021
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
Vi-TT
Single-dose V-TT administered to children and adolescents between the ages of 9 months to 15 years.
MCV-A vaccine
Single-dose of MCV-A vaccine (a meningococcal vaccine)
RECRUITING
Kwame Nkrumah University of Science and Technology, Kumasi
Collaborators (1)
Kwame Nkrumah University of Science and Technology
OTHER
University of Cambridge
OTHER
International Centre for Diarrhoeal Disease Research, Bangladesh
OTHER
Fondation Mérieux
OTHER
University of Maryland, Baltimore
OTHER
International Vaccine Institute
OTHER